TRANSDERMAL BUPRENORPHINE DOSAGE REGIMEN FOR ANALGESIA

Details for Australian Patent Application No. 2003297073 (hide)

Owner EURO-CELTIQUE S.A.

Inventors Spyker, Daniel A.; Reindenberg, Bruce E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003297073

PCT Number PCT/US2003/0397

PCT Pub. Number WO2004/054553

Priority 60/433,423 13.12.02 US

Filing date 15 December 2003

Wipo publication date 9 July 2004

International Classifications

A61K 009/70 Medicinal preparations characterised by special physical form - Web, sheet or filament bases

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/433,423 13.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003297073

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297074-TRANSDERMAL BUPRENORPHINE TO TREAT PAIN IN SICKLE CELL CRISIS

2003297072-Spring-loaded secondary seal for floating-roof storage tank